SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004673
Filing Date
2019-05-09
Accepted
2019-05-09 16:06:32
Documents
80
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20190331x10q.htm 10-Q 1270764
2 EX-10.1 mrsn-20190331ex10194900b.htm EX-10.1 60024
3 EX-10.2 mrsn-20190331ex10210c080.htm EX-10.2 452575
4 EX-31.1 mrsn-20190331ex3119e9f16.htm EX-31.1 11928
5 EX-31.2 mrsn-20190331ex3123503e9.htm EX-31.2 13616
6 EX-32.1 mrsn-20190331ex3213fd192.htm EX-32.1 16000
7 GRAPHIC mrsn20190331ex10194900b001.jpg GRAPHIC 4367
  Complete submission text file 0001558370-19-004673.txt   5921857

Data Files

Seq Description Document Type Size
8 EX-101.INS mrsn-20190331.xml EX-101.INS 1066574
9 EX-101.SCH mrsn-20190331.xsd EX-101.SCH 47869
10 EX-101.CAL mrsn-20190331_cal.xml EX-101.CAL 47395
11 EX-101.DEF mrsn-20190331_def.xml EX-101.DEF 140841
12 EX-101.LAB mrsn-20190331_lab.xml EX-101.LAB 414234
13 EX-101.PRE mrsn-20190331_pre.xml EX-101.PRE 319196
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 19810508
SIC: 2834 Pharmaceutical Preparations